Results 31 to 40 of about 9,366 (178)

Clinical and neurophysiological studies of chronic demyelinating polyneuropathy associated with monoclonal secretion

Медицинский совет, 2015
Paraproteinemic polyneuropathy accounts for up to 30% of chronic demyelinating polyneuropathies. The aim of this study was to determine the clinical and neurophysiological patterns of the nosology compared with chronic inflammatory demyelinating ...
M. A. Ginsberg, E. Y. Varlamova, V. V. Ryzhko, N. А. Suponeva, M. A. Piradov   +4 more
doaj   +1 more source

Dose Adjustment of Subcutaneous IgG in Chronic Inflammatory Demyelinating Polyneuropathy

Case Reports in Neurology, 2020
Chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) is an immune-mediated neuropathy that is characterized by a slowly progressive sensory and motor involvement lasting at least 2 months.
Alanood Alsolaihim, Steven K. Baker
doaj   +1 more source

How I Treat Chronic Inflammatory Demyelinating Polyneuropathy Podcast

Neurology and Therapy, 2023
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated neuropathy that typically presents with progressive or relapsing, symmetric, proximal, and distal weakness of upper and lower limbs, sensory involvement of at least ...
Urvi Desai
doaj   +1 more source

Clinical heterogeneity of chronic inflammatory demyelinating polyneuropathy: diagnostic challenges

Alʹmanah Kliničeskoj Mediciny, 2020
Сhronic inflammatory demyelinating polyneuropathy (CIDP) is the most prevalent acquired dysimmune neuropathy with clinical picture of symmetric motor and sensory disturbances.
A. S. Rizvanova, D. A. Grishina, N. A. Suponeva   +2 more
doaj   +1 more source

Ultrasound neuroimaging in chronic inflammatory demyelinating polyneuropathy

Анналы клинической и экспериментальной неврологии, 2017
We present the results of ultrasound study of 21 patients withchronic inflammatory demyelinating polyneuropathy (CIDP).In 100% cases were observed changes of the ultrasound structureof peripheral nerves. The ultrasound abnormalities were mostprominent in
N. B. Vuytsik, N. A. Suponeva, A. O. Chechetkin, M. A. Piradov, Z. A. Suslina   +4 more
doaj   +1 more source

The Lupus Damage Index Revision Program: Results From the Item Generation and Reduction Phases

Arthritis Care &Research, EarlyView.
Objective A data‐driven and expert/patient consensus‐based project to develop a revised Systemic Lupus International Collaborating Clinics (SLICC)/American College of Rheumatology (ACR) Damage Index (SDI) is under way supported by SLICC, ACR, and the Lupus Foundation of America. Our objective is to report the item generation and reduction phase results
Burak Kundakci, Megan R. W. Barber, Ann E. Clarke, Sindhu R. Johnson, Anselm Mak, Hermine I. Brunner, Murat Inanc, Rosalind Ramsey‐Goldman, Guillermo Ruiz‐Irastorza, Ellen M. Ginzler, John G. Hanly, Alexandra Legge, Cynthia Aranow, Laurent Arnaud, Nathalie Costedoat‐Chalumeau, Dafna D. Gladman, Søren Jacobsen, Michelle Petri, Clovis A. Silva, Évelyne Vinet, Alexandre E. Voskuyl, SDI Revision Literature Review Groups, SDI Revision Delphi Panel, SDI Revision Item Reduction Committee, SDI Revision Clinical Domain Groups, Ian N. Bruce   +25 more
wiley   +1 more source

POEMS Syndrome: 2026 Update on Diagnosis, Risk‐Stratification, and Management

American Journal of Hematology, EarlyView.
ABSTRACT Disease Overview POEMS syndrome is a life‐threatening syndrome due to an underlying plasma cell neoplasm. The major criteria for the syndrome are polyneuropathy, clonal plasma cell disorder (PCD), sclerotic bone lesions, elevated vascular endothelial growth factor, and the presence of Castleman disease.
Angela Dispenzieri
wiley   +1 more source

Chronic Inflammatory Polyneuropathy

Pediatric Neurology Briefs, 2007
Thirteen children with chronic inflammatory demyelinating polyneuropathy monitored between 1975 and 2005 are reported from Centre hospitalier universitaire Sainte-Justine, Montreal, Canada.
J Gordon Millichap
doaj   +1 more source

Sarcoid polyneuropathy masquerading as chronic inflammatory demyelinating polyneuropathy [PDF]

Muscle & Nerve, 2015
ABSTRACTIntroductionSarcoid polyneuropathy is a rare and clinically heterogeneous disorder that may be the initial presentation of sarcoidosis.MethodsWe report the clinical, electrophysiological, and pathological findings of a patient who carried a diagnosis of sensory‐predominant chronic inflammatory demyelinating polyneuropathy (CIDP) for over a ...
Singhal, Neel S, Irodenko, Viktoriya S, Margeta, Marta, Layzer, Robert B   +3 more
openaire   +4 more sources

Gephyrin Neurological Autoimmunity

Annals of Neurology, EarlyView.
Gephyrin is a postsynaptic scaffold protein essential for inhibitory neurotransmission. Gephyrin‐immunoglobulin G (IgG) was reported, decades ago, in a single case of paraneoplastic stiff‐person‐like syndrome, but its broader clinical relevance remains unknown.
Maria Chiara Pantuliano, Friederike A. Arlt, Naomi Arenson, Irena Dujmovic Basuroski, Divyanshu Dubey, Connie E. Lesnick, John R. Mills, Sean J. Pittock, Anastasia Zekeridou, Michael A. Lane, Andrew McKeon   +10 more
wiley   +1 more source